Stocks and Investing Stocks and Investing
Thu, July 26, 2018
Wed, July 25, 2018

Geoff Meacham Maintained (BIIB) at Hold with Increased Target to $320 on, Jul 25th, 2018


Published on 2024-10-26 07:09:34 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $295 to $320 on, Jul 25th, 2018.

Geoff has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoff


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018
Contributing Sources